Similar articles

• BCG and cancer.

  Bast RC Jr, Zbar B, Borsos T, Rapp HJ. Bast RC Jr, et al. N Engl J Med. 1974 Jun 27;290(26):1458-69. doi: 10.1056/NEJM197406272902605. N Engl J Med. 1974. PMID: 4598691 Review. No abstract available.
• [Immunotherapy of cancer with BCG].

  Yamamura Y, Azuma I. Yamamura Y, et al. Nihon Rinsho. 1974 Mar;32(3):542-53. Nihon Rinsho. 1974. PMID: 4603604 Review. Japanese. No abstract available.
• Use of BCG in the treatment of human neoplasms: a review.

  Nathanson L. Nathanson L. Semin Oncol. 1974 Dec;1(4):337-50. Semin Oncol. 1974. PMID: 4620439 Review. No abstract available.
• Immunotherapy for malignant disease.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1976 Sep 24;18(20):83-4. Med Lett Drugs Ther. 1976. PMID: 1066519 No abstract available.
• Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

  Schwarz MA, Gutterman JU, Hersh EM, Richman SP, Mavligit GM. Schwarz MA, et al. World J Surg. 1977 Sep;1(5):555-83. doi: 10.1007/BF01556181. World J Surg. 1977. PMID: 272083 No abstract available.